L i t t e r s o f newborn r a t pups were i n j e c t e d d a i l y from ages 0-1' days w i t h t h y r o x i n e (T4), 0.4 ~g l g r a m o f body weight, w h i l e l i ttermate c o n t r o l s were i n j e c t e d d a i l y w i t h s a l i n e . Other l i t t e r s were rendered h y p o t h y r o i d by i n j e c t i o n o f t h e mothers w i t h 50 mg p r o p y l t h i o u r a c i l (PTU) d a i l y from 18 days g e s t a t i o n v i a i n t r ag a s t r i c savage. C o n t r o l s r e c e i v e d an equal volume o f s a l i n e .
c r e a s i n g use o f t h y r o i d repiacement therapy i n t h e human neonate we s t u d i e d t h e e f f e c t s o f abnormal t h y r o i d s t a t e s on rGH d u r i n g t h e neonatal p e r i o d .
L i t t e r s o f newborn r a t pups were i n j e c t e d d a i l y from ages 0-1' days w i t h t h y r o x i n e (T4), 0.4 ~g l g r a m o f body weight, w h i l e l i ttermate c o n t r o l s were i n j e c t e d d a i l y w i t h s a l i n e . Other l i t t e r s were rendered h y p o t h y r o i d by i n j e c t i o n o f t h e mothers w i t h 50 mg p r o p y l t h i o u r a c i l (PTU) d a i l y from 18 days g e s t a t i o n v i a i n t r ag a s t r i c savage. C o n t r o l s r e c e i v e d an equal volume o f s a l i n e .
I n b o t h experimental groups, t h e developmental curve f o r rGH i n c o n t r o l s as measured by radioimnunoassay f e l l from 120 ngjml on day one t o 10 ng/ml on day 19. Both t h y r o x i n e and PTU t r e a t e l pups showed a c o n s i s t e n t depression i n rGH l e v e l s a t each age o f e a r l y development. The maximum d e f i c i t i n T4 animals was 6% o f c o n t r o l a t day 18, and i n PTU animals, was 14% o f c o n t r o l a t day 15. I n d i v i d u a l data p o i n t s f o r t r e a t e d and c o n t r o l animals were l o g transformed, f o l l o w i n g which t h e developmental p r o f i l e s were analyzed by a one way a n a l y s i s o f covariance. Both hyper-and i y p o t h y r o i d pups showed a s t a t i s t i c a l l y s i g n i f i c a c : d e f i c i e n c y o rGH throughout e a r l y development. The e a r l y suppression i n b o t h z o n d i t i o n s suggests t h e n e c e s s i t y f o r c a r e f u l t i t r a t i o n o f thyr o i d replacement therapy i n human c o n g e n i t a l hypothyroidism. In s m r y , 1) TL, alone is adequate therapy for CH iden tified early by screening programs, but is associated with delay ed TSH suppression in infants diagnosed on the basis of clinic41 symptomatology alone. 2) The peak rT3 levels associated with the Lnitial TSH suppression suggest an increase in the monodeiodina-:ion of Tq to fl3, or decreased clearance of flg which may indi-:ate the development of intracellular euthyroidism.
FFECTS OF THYROID HORMONE THERAPY IN CONGENITAL YPOTHYROIDISM (CH

HYPOGONADOTROPIC HYPOGONADISM (HHG) IN ACUTE INTERMIl
TENT PORPHYRIA (AIP), Nezam Radfar, Thomas P. Foley. Jr., Arthur K. Katoh, Robert S. Chabon, Univ. Pittsbu Ped., Mercy Hospital, Depts. of Ped. and Radiology Pittsburgh, PA HHG in AIP has not been reported. A 20 yr. old male with AIP and inappropriate secretion of ADH was hyposmic, tall (178 cm), eunuchoid (U/L, 0.84). had a high-pitched voice, absent facial hair and Tanner 2-3 pubic hair. His testes were small (R, 8 ml; L, 10 ml). Karyotype was XY. Basal serum FSH, 5.5 m~~/ m l ; LH, 5.6 m1~/ml and T, 54 ng/dl were all low and PRL was normal. Meal nocturnal LH (6.5 2 0.2 (SE) m~~/ m l ) was low and showed no perio. dic pulses. Mean nocturnal T (156 2 13 ngldl) was also low, wit1 minimal fluctuations between 2200 h and 0300 h; however, between 0300 h and 0800 h two peaks of T occurred simultaneously with those of cortisol. The responses of LH to LHRH and TSH and PRL to TRH were normal. Nocturnal GH secretion was characterized by 3 peaks. Basal GH was normal and increased to 16 ng/ml during AITT and remained above 10 ng/ml between 60 and 150 minutes. Basal T, 252 &dl, increased to 2049 ng/dl after 4 days of in hCG (5000 unitsld). Basal 24 h urine Pamino levulinic acid (ALA), 18 mg and porphobilinogen (PBG), 68 mg, respectively, were high and did not change after 4 days of hCG (ALA, 25 mgfd; PBG, 51 mg/d). Three attacks of AIP occurred during 8 months prior to T therapy, but none occurred during 7 months of hCG or T therapy. Conclusions: 1) Hypothalamic dysfunction in AIP may cause HHG 2) hCG and T do not alter ALA and PBG excretion and play protect these patients from re~eated attacks. Measurement of serum and urine C-peptide (CPR) have been used to demonstrate residual insulin producing capacity in diabetes. The duration and dynamics of residual 8-cell function have not been thoroughly investigated. Sequential measurement of serum and urine CPR were made during and after therapy for ketoacidosis in a 15 year old boy with JODM of 10 months duration. Serum CPR ranged from 0.3-0.6 nglml, approaching the lowest levels detectable by RIA. Urine C-peptide excretion increased over the 5 days of observation.
C --85 Urinary clearance and fractional excretion (CC-peptide/Ccreat ) of C-peptide also increased 6-10 fold.
Despite low serum CPR, these data are compatible with increased endogenous insulin production during therapy for ketoacidosis. Changes in renal blood flow or tubular disposition of C-peptide may have contributed to the progressive increase in urine C-peptide excretion.
, New York, New York.
and urinary excretion of tetrahydro-18-OH-DOC, measured by specific radioin 7 children with essential hypertendexamethasone-suppressible hyperaldoste nism when compared with 5 normotensive controls (plasma DOC: ree DOC: 0.1+0.01, free 18-OH-DOC: 0.8f0.2).
There was no corelation between DOC and 18-OH-DOC levels and plasma renin activ ty, severity or type of hypertension. During a continuous 5-da CTH infusion (40 U/24h) urinary 18-OH-DOC increased 20-50 fold n all groups. Plasma DOC concentration and urinary THDOC excre ion increased 20 fold, and urinary free DOC rose 20-50 fold in he control group and in the children with essential hypertenion. The highest increase of THDOC (50 fold) and free DOC (100 old) after ACTH was seen in the children with dexamethasone-sup ressible hyperaldosteronism. However neither the observed salt etention nor the rise in blood pressure after ACTH stimulation ere correlated with DOC or 18-OH-DOC in any of the groups. The ise in blood pressure after ACTH was independent of changes in BIOACTIVE AND IMMUNOREACTIVE SERUM LH IN NORMAL PREPUBERTAL AND PUBERTAL BOYS. E. 0. Reiter, Dufau, A. W. Root, and K. J. Catt. Dept. Peds., USE College of Medicine, Tampa, and Endocrinology and Reproduction Research Branch, NICHD, NIH, Bethesda.
The testosterone (T) secretion of collagenase-dispersed rat interstitial cells exposed to gonadotropin provides a highly sensitive in vitro bioassay (RICT) for LH (Dufau al, JCEM 39: 610, 1974) . The serum levels of biologically active (B) LH and the relationship to immunoreactive (I) LH have been studied in 12 prepubertal (PRE) (age 2-17, T=9.0 ngldl) and 12 pubertal (PUB) (age 10-16, T=164) normal males. Mean B-LH levels in PRE (<lmIU/ml, IRP-2-hMG) are significantly (p <.001) lower than in PUB (13.8'2.4 (XiSE). B-LH was undetectable in all PRE and not separable by Tanner stages in PUB. I-LH levels, measured by double-antibody RIA, in PRE (3.6f1.0) are also lower (p < .01) than in PUB (9.3t1.5). B/I ratios in PRE (<0.6) are lower than in PUB (2.1'0.7).
The B/I ratio in PRE is lower than in normal adult males (2.5t0.1) and closer to the levels reported in normal premenopausal women (1.2'0.1).
The B/I ratio in PUB does not differ from that in adult males. In conclusion: (1) The RICT bioassay method for quantitating serum LH is applicable to studies in childhood; (2) RIA measurements of LH apparently overestimate true bioactive concentrations in subjects with minimal pituitary LH secretion; (3) The similarity of B/I ratio in PRE males to adult premenopausal women and in PUB t o adult males suggests that sex steroids may modulate the biologic quality, as well as quantity, of pituitary LH secretion.
